Ausgabe 2/1998
Inhalt (9 Artikel)
mRNA differential display of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary gland tumors
Sarah J. Roberts-Thomson, Elizabeth G. Snyderwine
c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value
Rafael Molina, Judith Jo, Xavier Filella, Gabriel Zanon, Jaume Pahisa, Montserrat Muñoz, Blanca Farrus, Maria Luz Latre, Carmen Escriche, Jordi Estape, Antonio M. Ballesta
Suspected spinal cord compression in breast cancer patients: A multidisciplinary risk assessment
Charles Lu, Paul C. Stomper, Frank W. Drislane, Patrick Y. Wen, Caroline C. Block, Charles C. Humphrey, Catherine A. Collins, Ferenc Jolesz, James A. Talcott
Estimate of tumor growth time for breast cancer local recurrences: rapid growth after wake-up?
Romano Demicheli, Monica Terenziani, Gianni Bonadonna
Uptake and distribution of doxorubicin in hormone-manipulated human breast cancer cells in vitro
Marijke Bontenbal, Anieta M. Sieuwerts, Harry A. Peters, Wim L.J. van Putten, John A. Foekens, Jan G.M. Klijn
Additive effect of mifepristone and tamoxifen on apoptotic pathways in MCF-7 human breast cancer cells
M. Fathy El Etreby, Yayun Liang, Robert W. Wrenn, Patricia V. Schoenlein
Expanded phase II trial of paclitaxel in metastatic breast cancer: A Southwest Oncology Group study
Charles E. Geyer Jr., Stephanie J. Green, Carol M. Moinpour, Janet O'Sullivan, Donna K. Goodwin, Vikki A. Canfield, Frederick J. Meyers, C. Kent Osborne, Silvana Martino